Aurinia Pharmaceuticals (AUPH) Enterprise Value (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.83% |
| Dec 31, 2025 | -13.13% |
| Sep 30, 2025 | -11.64% |
| Jun 30, 2025 | -0.71% |
| Mar 31, 2025 | 12.71% |
| Dec 31, 2024 | -2.79% |
| Sep 30, 2024 | -5.53% |
| Jun 30, 2024 | -3.30% |
| Mar 31, 2024 | 8.72% |
| Dec 31, 2023 | -3.73% |
| Sep 30, 2023 | 3.65% |
| Jun 30, 2023 | 2.99% |
| Mar 31, 2023 | 7.15% |
| Dec 31, 2022 | -3.38% |
| Sep 30, 2022 | 3.85% |
| Jun 30, 2022 | 6.45% |
| Mar 31, 2022 | 10.15% |
| Dec 31, 2021 | -62.74% |
| Sep 30, 2021 | 10.15% |
| Jun 30, 2021 | 8.48% |
| Mar 31, 2021 | 12.56% |
| Dec 31, 2020 | -60.13% |
| Sep 30, 2020 | -7.03% |
| Jun 30, 2020 | 15.24% |
| Mar 31, 2020 | 10.40% |
| Dec 31, 2019 | -127.46% |
| Sep 30, 2019 | -2.32% |
| Jun 30, 2019 | 6.32% |
| Mar 31, 2019 | -11.52% |
| Dec 31, 2018 | -9.54% |
| Sep 30, 2018 | 13.15% |
| Jun 30, 2018 | -0.82% |
| Mar 31, 2018 | 24.35% |
| Dec 31, 2017 | -98.14% |
| Sep 30, 2017 | 51.29% |
| Jun 30, 2017 | 11.08% |
| Mar 31, 2017 | -409.76% |
| Dec 31, 2016 | -157.80% |
| Sep 30, 2016 | -26.86% |
| Jun 30, 2016 | -15.12% |
| Mar 31, 2016 | 33.14% |
| Dec 31, 2015 | 23.47% |
| Sep 30, 2015 | 37.08% |
| Jun 30, 2015 | 100.00% |